Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07123038 · ClinicalTrials.gov registry record

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

A clinical trial of Rheumatoid Arthritis (RA) and Hidradenitis Suppurativa (HS), sponsored by Sonoma Biotherapeutics.

Recruiting
Registry status
36
Enrollment target
10
Study locations

NCT07123038 is a study of Rheumatoid Arthritis (RA) and Hidradenitis Suppurativa (HS) that is actively recruiting participants, run by Sonoma Biotherapeutics. The registered enrollment target is 36 participants, below the 266-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (86% lower). The trial reports 10 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07123038, a study of Rheumatoid Arthritis (RA) and Hidradenitis Suppurativa (HS), is actively recruiting participants, sponsored by Sonoma Biotherapeutics.

RECRUITING
Registry status
36 participants
Enrollment target
10
Study locations

Study Summary

To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.

Conditions Studied

Rheumatoid Arthritis (RA) Hidradenitis Suppurativa (HS)

Interventions

  • OTHER Long Term Safety Monitoring Procedures

Study Locations (10)

Massachusetts

  • Tufts University - Boston
  • Massachusetts General Hospital - Boston
  • Brigham and Women's Hospital - Boston

California

  • UCSF Medical Center - San Francisco
  • Stanford Medical Center - Stanford

Colorado

  • University of Colorado - Aurora

Illinois

  • Northwestern University - Chicago

Minnesota

  • University of Minnesota - Minneapolis

North Carolina

  • Duke University - Durham

Texas

  • The University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-07-22
Est. Completion 2040-12

Sponsor

Sonoma Biotherapeutics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07123038

The ClinicalTrials.gov registry entry for NCT07123038 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (86% lower). The listed sponsor is Sonoma Biotherapeutics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Rheumatoid Arthritis (RA) appearing as the primary indexed condition, and to 1 intervention - of which Long Term Safety Monitoring Procedures is the first listed.

NCT07123038 reports 10 study locations spanning 7 distinct geographic areas - top geographies include Massachusetts, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT07123038 about?

NCT07123038 is a clinical study titled "A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic". To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.

What is the current status of trial NCT07123038?

This trial is currently recruiting. The enrollment target is 36 participants. The study started on 2025-07-22. Estimated completion is 2040-12.

What conditions does trial NCT07123038 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis (RA), Hidradenitis Suppurativa (HS).

What interventions are being tested in trial NCT07123038?

The interventions under investigation include: Long Term Safety Monitoring Procedures (OTHER).

Who is sponsoring clinical trial NCT07123038?

This trial is sponsored by Sonoma Biotherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07123038 being conducted?

This trial has 10 study locations across California, Colorado, Illinois, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis (RA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis (RA)

All registered trials for this condition

Hidradenitis Suppurativa (HS)

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.